A phase II trial of gemcitabine in a fixed dose rate infusion combined with cisplatin in patients with operable biliary tract carcinomas.
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Cisplatin; Gemcitabine
- Indications Biliary cancer
- Focus Therapeutic Use
- Acronyms ABC
- 17 Dec 2009 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
- 06 Nov 2007 New trial record.